Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical...
![download Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]](https://fdocuments.us/public/t1/desktop/images/details/download-thumbnail.png)
of 5
-
Upload
shyam-sunder -
Category
Documents
-
view
217 -
download
0
Transcript of Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical...
-
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
1/5
-
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
2/5
-
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
3/5
-
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
4/5
-
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
5/5
